Damora Therapeutics, Inc. (DMRA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $260.53M | +1420.7% |
| 2024 | $17.13M | -55.2% |
| 2023 | $38.23M | -47.8% |
| 2022 | $73.19M | -40.1% |
| 2021 | $122.22M | -28.8% |
| 2020 | $171.60M | +203.1% |
| 2019 | $56.61M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $260.53M | +1420.7% |
| 2024 | $17.13M | -55.2% |
| 2023 | $38.23M | -47.8% |
| 2022 | $73.19M | -40.1% |
| 2021 | $122.22M | -28.8% |
| 2020 | $171.60M | +203.1% |
| 2019 | $56.61M | — |